Noteworthy - Pharmaceutical Executive

ADVERTISEMENT

Noteworthy

Tracking Innovation in 2013's New Molecular Entities

January 6, 2014

Patricia Van Arnhum reviews 2013's crop of the new molecular entities and new biologics license applications approved by FDA.

ADVERTISEMENT

Click here